$30.4M of new contracted sales in the half resulting in contracted revenue able to be recognised in FY22 increasing to $27.1M, up 25% on the prior corresponding period (pcp)

 H1 FY22 revenue of $12.9M, up 16% on pcp

 Gross profit of $10.9M (85% gross profit margin), up from $9.8M on pcp

 Underlying EBITDA loss of $3.2M, is in line with management expectations given planned investment in growth

 Milestone $23.3M contract with the Commonwealth of Australia as part of Consortium led by Leidos Australia

 Material contracts signed with Sydney Local Health District, Queen’s Hospital Burton and a 3- year extension for support and maintenance with Royal Derby Hospital

 Acquisition of Silverlink PCS Software Ltd, positioning Alcidion to deliver a cloud-native, modern and modular Electronic Patient/Medical Record (EPR/EMR)

 Cash balance of $18.9M as at 31 December 2021

Alcidion’s Group Managing Director Kate Quirke said, “The first half of financial year 2022 was a transformational one for Alcidion, and a significant step in our goal of becoming a leading global healthcare technology and informatics company. In December, we signed the largest contract in the Company’s history and completed the acquisition of Silverlink, which will enable us to compete alongside global vendors with a cloud native, modern and modular EPR offering”.

“Despite challenging conditions across our markets, we strengthened and grew our business, securing new sales with total contract value (TCV) of $30.4M. This included the major healthcare IT contract with the Commonwealth of Australia which is now underway, and we look forward to delivering the foundational component, the longitudinal health record. While significant in both size and duration, as our first Commonwealth contract the opportunity also demonstrates both the scalability and capability of Alcidion’s solutions to address the challenge of integrating care across all healthcare sectors.”

“The Coronavirus pandemic and the uncertainty it creates continues to challenge healthcare providers worldwide, with increasing COVID case numbers impacting staffing levels and placing pressure on hospital waitlists, particularly in the UK market. I am currently in the UK meeting with both customers and our team and I am amazed and very grateful for the incredible work everyone continues to deliver every day.”

“While COVID has certainly influenced the speed of procurement and contract negotiation, we are pleased to see an increase in opportunities for Miya Flow, which allow our customers to realise early benefits and add other Miya Precision modules over time. The feedback in response to our acquisition of Silverlink has been very positive and our customers are increasingly understanding the power and value of the combined offering.”

Disc: Held